(Q38820614)

6 September 2017

FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target (English)

1 reference

6 September 2017

1 reference

Masaaki Kuda

1

1 reference

6 September 2017

Kenichi Kohashi

2

1 reference

6 September 2017

Yuichi Yamada

3

1 reference

6 September 2017

Akira Maekawa

4

1 reference

6 September 2017

Yoshiaki Kinoshita

5

1 reference

6 September 2017

Tetsuya Nakatsura

6

1 reference

6 September 2017

Yukihide Iwamoto

7

1 reference

6 September 2017

Tomoaki Taguchi

8

1 reference

6 September 2017

Yoshinao Oda

9

1 reference

6 September 2017

9 November 2015

1 reference

6 September 2017

1 reference

6 September 2017

37

1 reference

6 September 2017

4

1 reference

6 September 2017

5213-5223

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-015-4351-9

6 September 2017

0 references

cites work

Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Allelotype of pediatric rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

FoxM1 is required for execution of the mitotic programme and chromosome stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Forkhead box M1 transcription factor: a novel target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

The Forkhead Box m1 transcription factor stimulates the proliferation of tumor cells during development of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

The FOXM1 transcriptional factor promotes the proliferation of leukemia cells through modulation of cell cycle progression in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Expression of FoxM1 is required for the proliferation of medulloblastoma cells and indicates worse survival of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

A novel FoxM1-caveolin signaling pathway promotes pancreatic cancer invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

FOXM1 is an oncogenic mediator in Ewing Sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Identification of cell cycle-regulated genes periodically expressed in U2OS cells and their regulation by FOXM1 and E2F transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Identification of FoxM1/Bub1b signaling pathway as a required component for growth and survival of rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

VEGF-targeted therapy: mechanisms of anti-tumour activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Close correlation between CXCR4 and VEGF expression and frequent CXCR7 expression in rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

FoxM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Critical role and regulation of transcription factor FoxM1 in human gastric cancer angiogenesis and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

FOXO3a represses VEGF expression through FOXM1-dependent and -independent mechanisms in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Detection of fusion gene transcripts in fresh-frozen and formalin-fixed paraffin-embedded tissue sections of soft-tissue sarcomas after laser capture microdissection and rt-PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Prognostic significance of AKT/mTOR and MAPK pathways and antitumor effect of mTOR inhibitor in NF1-related and sporadic malignant peripheral nerve sheath tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Aberrant FoxM1B expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Transgenic expression of the forkhead box M1 transcription factor induces formation of lung tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Genome-wide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Addiction to elevated insulin-like growth factor I receptor and initial modulation of the AKT pathway define the responsiveness of rhabdomyosarcoma to the targeting antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Targeting wild-type and mutant p53 with small molecule CP-31398 blocks the growth of rhabdomyosarcoma by inducing reactive oxygen species-dependent apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Dual blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

AKT (v-akt murine thymoma viral oncogene homolog 1) and N-Ras (neuroblastoma ras viral oncogene homolog) coactivation in the mouse liver promotes rapid carcinogenesis by way of mTOR (mammalian target of rapamycin complex 1), FOXM1 (forkhead box M1)/

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Sonic Hedgehog-dependent proliferation in a series of patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Overexpression of FOXM1 predicts poor prognosis and promotes cancer cell proliferation, migration and invasion in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Cancer genetics and genomics of human FOX family genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

RAS signaling dysregulation in human embryonal Rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Hedgehog pathway activity in pediatric embryonal rhabdomyosarcoma and undifferentiated sarcoma: a report from the Children's Oncology Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Oncogene mutation profiling of pediatric solid tumors reveals significant subsets of embryonal rhabdomyosarcoma and neuroblastoma with mutated genes in growth signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Activation of the hedgehog pathway confers a poor prognosis in embryonal and fusion gene-negative alveolar rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Chromosomal localization of the human rhabdomyosarcoma locus by mitotic recombination mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4351-9

Chemokine receptor CXCR4 expression is correlated with VEGF expression and poor survival in soft-tissue sarcoma

21 January 2018

1 reference

12 December 2020

Reduced expression of SMARCB1/INI1 protein in synovial sarcoma.

1 reference

12 December 2020

CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis

1 reference

12 December 2020

Overexpressed transcription factor FOXM1 is a potential diagnostic and adverse prognostic factor in postoperational gastric cancer patients.

1 reference

12 December 2020

The dual inhibitory effect of thiostrepton on FoxM1 and EWS/FLI1 provides a novel therapeutic option for Ewing's sarcoma

1 reference

12 December 2020

Down-regulation of FoxM1 by thiostrepton or small interfering RNA inhibits proliferation, transformation ability and angiogenesis, and induces apoptosis of nasopharyngeal carcinoma cells

1 reference

12 December 2020

FOXM1 is a downstream target of Gli1 in basal cell carcinomas

1 reference

12 December 2020

Pharmacological inhibition of the Hedgehog pathway prevents human rhabdomyosarcoma cell growth

1 reference

12 December 2020

FOXM1: From cancer initiation to progression and treatment.

1 reference

12 December 2020

Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma.

1 reference

12 December 2020

Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma

1 reference

12 December 2020

Array-Based Comparative Genomic Hybridization Identifies CDK4 and FOXM1 Alterations as Independent Predictors of Survival in Malignant Peripheral Nerve Sheath Tumor

1 reference

12 December 2020

Correspondence re: Parham DM. Pathologic classification of rhabdomyosarcomas and correlations with molecular studies. Mod Pathol 2001;14:506-14

1 reference

12 December 2020

FOXM1 expression predicts the prognosis in hepatocellular carcinoma patients after orthotopic liver transplantation combined with the Milan criteria

1 reference

12 December 2020

FoxM1: at the crossroads of ageing and cancer

1 reference

12 December 2020

10.1007/S13277-015-4351-9

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

0 references

1 reference